Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amandine Maulard

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
British Journal of Cancer|December 18, 2019
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumoursCatherine Genestie, Félix Blanc-Durand, Aurélie Auguste, et al.
Human Pathology|April 30, 2024
Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysisCarine Ngo, Sophie Cotteret, Imène Deneche, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2020
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancerAlexandra Leary, Catherine Genestie, Félix Blanc-Durand, et al.
Biomarker Research|October 20, 2023
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patientsMaria Kfoury, Reda El Hazzaz, Claire Sanson, et al.
Gynecologic Oncology|November 12, 2022
Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factorsKanta Ka, Adrien Laville, Elie Rassy, et al.
Molecular Cancer|November 6, 2023
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluidCyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancerJuan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, et al.
The New England Journal of Medicine|February 28, 2024
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical CancerMarie Plante, Janice S Kwon, Sarah Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical HysterectomySarah E Ferguson, Lori A Brotto, Janice Kwon, et al.
ACS Nano|June 24, 2024
Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical CancerCyrus Chargari, Pauline Maury, Matthieu Texier, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
British Journal of Cancer|December 18, 2019
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumoursCatherine Genestie, Félix Blanc-Durand, Aurélie Auguste, et al.
Human Pathology|April 30, 2024
Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysisCarine Ngo, Sophie Cotteret, Imène Deneche, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2020
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancerAlexandra Leary, Catherine Genestie, Félix Blanc-Durand, et al.
Biomarker Research|October 20, 2023
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patientsMaria Kfoury, Reda El Hazzaz, Claire Sanson, et al.
Gynecologic Oncology|November 12, 2022
Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factorsKanta Ka, Adrien Laville, Elie Rassy, et al.
Molecular Cancer|November 6, 2023
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluidCyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancerJuan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, et al.
The New England Journal of Medicine|February 28, 2024
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical CancerMarie Plante, Janice S Kwon, Sarah Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical HysterectomySarah E Ferguson, Lori A Brotto, Janice Kwon, et al.
ACS Nano|June 24, 2024
Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical CancerCyrus Chargari, Pauline Maury, Matthieu Texier, et al.
Pageof 4